KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2025)

Rigel Pharmaceuticals has reported Debt Ratio over the past 7 years, most recently at 0.16 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.16 for Q4 2025, down 56.08% from a year ago — trailing twelve months through Dec 2025 was 0.16 (down 56.08% YoY), and the annual figure for FY2025 was 0.16, down 56.08%.
  • Debt Ratio for Q4 2025 was 0.16 at Rigel Pharmaceuticals, down from 0.25 in the prior quarter.
  • Over the last five years, Debt Ratio for RIGL hit a ceiling of 0.52 in Q3 2023 and a floor of 0.09 in Q1 2021.
  • Median Debt Ratio over the past 5 years was 0.32 (2022), compared with a mean of 0.31.
  • Biggest five-year swings in Debt Ratio: soared 220.19% in 2022 and later tumbled 56.08% in 2025.
  • Rigel Pharmaceuticals' Debt Ratio stood at 0.12 in 2021, then surged by 146.85% to 0.29 in 2022, then skyrocketed by 73.07% to 0.51 in 2023, then dropped by 28.42% to 0.36 in 2024, then tumbled by 56.08% to 0.16 in 2025.
  • The last three reported values for Debt Ratio were 0.16 (Q4 2025), 0.25 (Q3 2025), and 0.29 (Q2 2025) per Business Quant data.